These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19347729)

  • 21. Large-scale analysis of DNA methylation in chronic lymphocytic leukemia.
    Rahmatpanah FB; Carstens S; Hooshmand SI; Welsh EC; Sjahputera O; Taylor KH; Bennett LB; Shi H; Davis JW; Arthur GL; Shanafelt TD; Kay NE; Wooldridge JE; Caldwell CW
    Epigenomics; 2009 Oct; 1(1):39-61. PubMed ID: 20495622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.
    Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
    Epigenetics; 2016 May; 11(5):335-43. PubMed ID: 27052808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia.
    Tsirigotis P; Pappa V; Labropoulos S; Papageorgiou S; Kontsioti F; Dervenoulas J; Papageorgiou E; Panani A; Mantzios G; Economopoulos T; Raptis S
    Eur J Haematol; 2006 Mar; 76(3):230-6. PubMed ID: 16412137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
    Huang D; Ovcharenko I
    BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
    Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
    Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
    Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
    Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients.
    Subhash S; Kanduri M
    J Vis Exp; 2017 Jun; (124):. PubMed ID: 28654059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia.
    Hanoun M; Eisele L; Suzuki M; Greally JM; Hüttmann A; Aydin S; Scholtysik R; Klein-Hitpass L; Dührsen U; Dürig J
    PLoS One; 2012; 7(3):e34347. PubMed ID: 22470559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia.
    Dunwell TL; Dickinson RE; Stankovic T; Dallol A; Weston V; Austen B; Catchpoole D; Maher ER; Latif F
    Epigenetics; 2009 May; 4(4):265-9. PubMed ID: 19550140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments.
    Cahill N; Bergh AC; Kanduri M; Göransson-Kultima H; Mansouri L; Isaksson A; Ryan F; Smedby KE; Juliusson G; Sundström C; Rosén A; Rosenquist R
    Leukemia; 2013 Jan; 27(1):150-8. PubMed ID: 22922567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
    Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
    Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia.
    Kulis M; Heath S; Bibikova M; Queirós AC; Navarro A; Clot G; Martínez-Trillos A; Castellano G; Brun-Heath I; Pinyol M; Barberán-Soler S; Papasaikas P; Jares P; Beà S; Rico D; Ecker S; Rubio M; Royo R; Ho V; Klotzle B; Hernández L; Conde L; López-Guerra M; Colomer D; Villamor N; Aymerich M; Rozman M; Bayes M; Gut M; Gelpí JL; Orozco M; Fan JB; Quesada V; Puente XS; Pisano DG; Valencia A; López-Guillermo A; Gut I; López-Otín C; Campo E; Martín-Subero JI
    Nat Genet; 2012 Nov; 44(11):1236-42. PubMed ID: 23064414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced rai stage in patients with chronic lymphocytic leukaemia correlates with simultaneous hypermethylation of plural tumour suppressor genes.
    Forsterová K; Votavová H; Schwarz J; Karban J; Stuka C; Trněný M
    Folia Biol (Praha); 2010; 56(4):158-64. PubMed ID: 20974048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development.
    Smith EN; Ghia EM; DeBoever CM; Rassenti LZ; Jepsen K; Yoon KA; Matsui H; Rozenzhak S; Alakus H; Shepard PJ; Dai Y; Khosroheidari M; Bina M; Gunderson KL; Messer K; Muthuswamy L; Hudson TJ; Harismendy O; Barrett CL; Jamieson CH; Carson DA; Kipps TJ; Frazer KA
    Blood Cancer J; 2015 Apr; 5(4):e303. PubMed ID: 25860294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
    Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia.
    Oakes CC; Seifert M; Assenov Y; Gu L; Przekopowitz M; Ruppert AS; Wang Q; Imbusch CD; Serva A; Koser SD; Brocks D; Lipka DB; Bogatyrova O; Weichenhan D; Brors B; Rassenti L; Kipps TJ; Mertens D; Zapatka M; Lichter P; Döhner H; Küppers R; Zenz T; Stilgenbauer S; Byrd JC; Plass C
    Nat Genet; 2016 Mar; 48(3):253-64. PubMed ID: 26780610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
    Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z
    Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia.
    Baer C; Oakes CC; Ruppert AS; Claus R; Kim-Wanner SZ; Mertens D; Zenz T; Stilgenbauer S; Byrd JC; Plass C
    Int J Cancer; 2015 Sep; 137(6):1352-61. PubMed ID: 25704289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders.
    Jost E; do O N; Dahl E; Maintz CE; Jousten P; Habets L; Wilop S; Herman JG; Osieka R; Galm O
    Leukemia; 2007 Mar; 21(3):505-10. PubMed ID: 17230231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.